TECNIS ODYSSEY TORIC II IOL DRT225 (REF DRT2250210)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TEC ODYSSEY TOR II SMPCY 21.0D CYL2.25 · Class 3 · Implant
All models of TECNIS ODYSSEY TORIC II IOL (106)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05050474811966), received between Dec 30, 2024 and Jun 1, 2026 — classified as 4 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
Patient problems
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Blurred Vision1
- Halo1
- Visual Disturbances1
- Visual Impairment1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJun 1, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A MULTIFOCAL TORIC INTRAOCULAR LENS (IOL) WAS EXPLANTED FROM A PATIENT'S RIGHT EYE DUE TO THE PATIENT EXPERIENCING BLURRY VISION. THERE WAS NO REPORTED HARM TO THE PATIENT OR USER. THE PRODUCT IS NOT AVAILABLE FOR INVESTIGATION. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Blurred Vision
MAUDE report 25355481 ↗InjuryJan 7, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE JOHNSON AND JOHNSON (JNJ) INTRAOCULAR LENS (IOL) WAS IMPLANTED INTO THE PATIENT¿S EYE. HOWEVER, THE PATIENT SEEMED TO NEED A STRONGER DIOPTER OF THE SAME LENS. THE ISSUE WAS NOTED DURING AN OFFICE VISIT 1 MONTH POST-OPERATIVELY. THE SYMPTOMS WERE NOT DEBILITATING. THE IOL WAS SUBSEQUENTLY EXPLANTED DUE. THE EXPLANTED IOL MODEL DRT225 AND 21.0 DIOPTER WAS REPLACED WITH THE SAME MODEL DRT225 BUT 21.5 DIOPTER. REPORTEDLY, THE PATIENT IS DOING WELL.
Patient problems: Visual Impairment
MAUDE report 23994364 ↗InjuryNov 6, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PRELOADED JOHNSON AND JOHNSON (JNJ) INTRAOCULAR LENS (IOL) WAS IMPLANTED INTO THE PATIENT¿S LEFT EYE. THE PATIENT EXPERIENCED GLARE AND HALOS THAT SIGNIFICANTLY AFFECTED THEIR DAILY ACTIVITIES AND EXPRESSED A DESIRE TO TRY A LENS WITH LESS GLARE. THE IOL WAS EXPLANTED THE REPLACEMENT LENS IS UNKNOWN. THERE WAS NO INCISION ENLARGEMENT AND NO VITRECTOMY. THE MEDICATION PRESCRIBE WAS WITHIN THE STANDARD OF CARE. THE PATIENT HAS FULLY RECOVERED. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Halo; Visual Disturbances
MAUDE report 23493557 ↗InjuryDec 30, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ABOUT ONE WEEK AFTER THE PRELOADED TORIC INTRAOCULAR LENS WAS IMPLANTED, THE PATIENT'S DISTANT VISUAL ACUITY DIDN'T IMPROVED MUCH. THE DISTANCE VISUAL ACUITY WAS 0.6 WITH THE NAKED EYE AND NEAR VISUAL ACUITY WAS 40 CM WITH 0.2. THE PATIENT DID NOT PRESENT WITH ANY CORNEAL ABNORMALITY OR FUNDUS DISEASE. THE PATIENT IS UNDER OBSERVATION, BUT THE IMPLANTATION OF A LENS FROM A DIFFERENT MANUFACTURER IS BEING CONSIDERED. THERE WERE NO PATIENT INJURIES, AND NO OTHER MEDICAL INTERVENTION WAS REQUIRED. THROUGH FOLLOW-UP WE LEARNED, THAT THE LENS WAS EXPLANTED ON (B)(6) 2024 AND THE INCISION WAS ENLARGED. A LENS FROM A DIFFERENT MANUFACTURER WAS IMPLANTED. THE PREOPERATIVE UNCORRECTED VISUAL ACUITY WAS 0.3 AND THE CORRECTED VISUAL ACUITY WAS 0.8. THE POSTOPERATIVE UNCORRECTED VISUAL ACUITY WAS 0.6 AND THE CORRECTED VISUAL ACUITY IS UNKNOWN. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 21044607 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page